Evidence map›Paper›PMID 25549244›Full record

ArticlePloS one2014

Loss of FADS2 function severely impairs the use of HeLa cells as an in vitro model for host response studies involving fatty acid effects.

Anke Jaudszus, Christian Degen, Stephan W Barth, Martin Klempt, Wiebke Schlörmann, Alexander Roth, Carsten Rohrer, Helga Sauerwein, Konrad Sachse, Gerhard Jahreis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Anke JaudszusMax Rubner-Institut (Federal Research Institute of Nutrition and Food), Department of Physiology and Biochemistry of Nutrition, Karlsruhe, Germany.
Christian DegenInstitute of Nutrition, Department of Nutritional Physiology, Friedrich Schiller University of Jena, Jena, Germany.
Stephan W BarthMax Rubner-Institut (Federal Research Institute of Nutrition and Food), Department of Physiology and Biochemistry of Nutrition, Karlsruhe, Germany.
Martin KlemptMax Rubner-Institut, Federal Research Institute of Nutrition and Food, Department of Safety and Quality of Milk and Fish Products, Kiel, Germany.
Wiebke SchlörmannInstitute of Nutrition, Department of Nutritional Physiology, Friedrich Schiller University of Jena, Jena, Germany.
Alexander RothMax Rubner-Institut (Federal Research Institute of Nutrition and Food), Department of Physiology and Biochemistry of Nutrition, Karlsruhe, Germany.
Carsten RohrerInstitute of Nutrition, Department of Nutritional Physiology, Friedrich Schiller University of Jena, Jena, Germany.
Helga SauerweinInstitute of Animal Science, Physiology & Hygiene Unit, University of Bonn, Bonn, Germany.
Konrad SachseFriedrich-Loeffler-Institut (Federal Research Institute for Animal Health), Institute of Molecular Pathogenesis, Jena, Germany.
Gerhard JahreisInstitute of Nutrition, Department of Nutritional Physiology, Friedrich Schiller University of Jena, Jena, Germany.
Friedrich Schiller University Jena · DEMax Rubner Institut · DEFriedrich-Loeffler-Institut · DEUniversity of Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

scopeEstablished epithelial cell lines equipped with pattern recognition receptors such as the Toll-like receptor (TLR)-2 are common tools for immune response studies on invading pathogens, e.g. the obligate intracellular species of Chlamydia. Moreover, such models are widely used to elucidate fatty acid-mediated immune effects. In several transformed cell lines, however, unusual loss of metabolic functions was described. The cell lines A549 and HeLa are poorly characterized in this respect. Therefore, we comparatively assessed the metabolic capacity of A549 and HeLa prior to proposed application as in vitro model for fatty acid effects on chlamydial infection. METHODOLOGY/PRINCIPAL

findingsWe incubated both cell lines either with substrates (C18:2n-6 or C18:3n-3) or products (C18:3n-6, C18:4n-3) of fatty acid desaturase-2 (FADS2), and analysed the fatty acid profiles after 24 h and 72 h by gas chromatography. Based on these data, we suspected that the complete discontinuation of normal biosynthesis of long-chain polyunsaturated fatty acids (LC-PUFA) in HeLa was due to loss of FADS2 function. Consequently, prostaglandin E2 (PGE2) formation was less inducible by TLR2 stimulation in HeLa, likely as a result of not only insufficient supply of precursors but also weak cyclooxygenase-2 (COX-2) response. In accordance, Chlamydia infection rates were consistently lower in HeLa than in A549. Sequence analysis revealed no alteration within the FADS2 gene in HeLa. The FADS2 expression level, however, was significantly lower and, in contrast to A549, not regulated by C18:2n-6. A549 exhibited regular fatty acid metabolism and enzyme functionality. CONCLUSIONS/SIGNIFICANCE: Our data show that HeLa cells considerably differ from A549 at several stages of fatty acid metabolism. The poor metabolic potential of HeLa, mainly concerning FADS2 upstream of COX-2 function, calls into question whether these cells represent a good model to unveil fatty acid or downstream eicosanoid effects in the course of intracellular bacterial infection.

Indexed as

ChlamydiaChlamydia InfectionsCyclooxygenase 2DinoprostoneFatty Acid DesaturasesFatty AcidsHeLa CellsHumansToll-Like Receptor 2Cyclooxygenase 2DinoprostoneFADS2 protein, humanFatty Acid DesaturasesFatty AcidsPTGS2 protein, humanTLR2 protein, humanToll-Like Receptor 2

Identifiers

PMID25549244
PMCPMC4280191
OpenAlexW1988662722

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.